Pharmacists in Springfield, Vermont


13 Pharmacists found in Springfield
female pharmacist

Aman Preet Saini


Pharmacist
25 Ridgewood Rd, Springfield, VT 05156
802-885-7574    

female pharmacist

Amanda M Lamkins


Pharmacist
25 Ridgewood Rd, Springfield, VT 05156
802-885-2151    

female pharmacist

Caroline Kirkpatrick


Pharmacist
25 Ridgewood Rd, Springfield, VT 05156
802-885-7540    



male pharmacist

Dr. Connor Richard Kelley, PHARMACIST


Pharmacist
25 Ridgewood Rd, Springfield, VT 05156
802-885-2151    

female pharmacist

Courtney Gilmore


Pharmacist
2 Chester Rd Ste 25, Springfield, VT 05156
802-885-5311    

male pharmacist

Dr. Derek Michael Caraccia, PHARMD


Pharmacist
2 Chester Rd Ste 25, Springfield, VT 05156
802-885-5311    

male pharmacist

Emanuel M Joseph, PHARMD


Pharmacist
55 Springfield Plaza Rd, Springfield, VT 05156
802-885-5311    

male pharmacist

Lester Gale Peck, R.PH., PHARM. D.


Pharmacist
2 Chester Rd, Suite 25, Springfield, VT 05156
802-885-5311     802-885-9330

female pharmacist

Madhulatha Reddy Malireddy


Pharmacist
2 Chester Rd, Suite 25 Springfield Plaza, Springfield, VT 05156
802-885-5311    

male pharmacist

Muralikrishna Narra


Pharmacist
2 Chester Rd, Suite 25, Springfield, VT 05156
802-885-5311    

female pharmacist

Patricia Ann Smith, R.PH.


Pharmacist
6 Hill Pl, Springfield, VT 05156
802-885-1107    

male pharmacist

Simon White


Pharmacist
262 River St, Springfield, VT 05156
802-885-6400    

male pharmacist

Vincent Stoodley, PHARMD


Pharmacist
262 River St, Springfield, VT 05156
802-885-6400     802-885-6415


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.